Voyager Therapeutics Maximum Drawdown
| VYGR Stock | | | USD 4.17 0.27 6.92% |
Maximum Drawdown (or MDD) is another indicator of risk. It is the reduction in asset value after a series of losing trades. This is normally calculated by getting the difference between a relative peaks in equity capital minus a relative trough. Below is Voyager Therapeutics's current Maximum Drawdown with peer comparisons and related risk metrics.
Current Maximum Drawdown Value
At 30.91, Voyager Therapeutics exhibits a severe peak-to-trough loss in Maximum Drawdown. Voyager Therapeutics's maximum drawdown exceeds 30%, reflecting significant downside exposure.
Maximum Drawdown | = | MAX(HIGH - LOW) |
| = | 30.91 | |
| MAX | = | Maximum notation for the range of returns on Voyager Therapeutics |
Maximum Drawdown Peers Comparison
Among sector peers, Voyager Therapeutics's Maximum Drawdown of 30.91 is below the 34.29 group average. The range runs from 13.9 (Entrada Therapeutics) to 58.41 (Vanda Pharmaceuticals). Voyager Therapeutics's shallower drawdown relative to peers indicates more contained historical downside.
Maximum Drawdown Relative To Other Indicators
The chart below plots Maximum Drawdown against Maximum Drawdown for Voyager Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Maximum Drawdown while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Voyager Therapeutics's Maximum Drawdown reads
30.91 while Maximum Drawdown reads
30.91 , a
1.00 ratio between the two. The two measures are closely aligned in magnitude for Voyager Therapeutics.
Methodology, Assumptions & Data Sources
Voyager Therapeutics has a current Maximum Drawdown reading of 30.91. The Maximum Drawdown for Voyager Therapeutics applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.
Other Technical Indicators